Toronto, Canada

Hal K Berman

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignee: University of California. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hal K Berman: Innovator in Cancer Detection

Introduction

Hal K Berman is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of cancer detection through his innovative research and development of diagnostic methods. His work focuses on identifying pre-cancerous conditions, which can lead to earlier intervention and improved patient outcomes.

Latest Patents

Hal K Berman holds 1 patent for his invention titled "Cancer biomarkers and methods of use thereof." This patent provides detection methods for identifying a pre-cancerous epithelial cell signature. The invention also includes reagents that are useful in these detection methods. His subject detection method is applicable in various imaging, diagnostic, prognostic, and patient monitoring techniques.

Career Highlights

Throughout his career, Hal K Berman has worked with prestigious institutions, including the University of California and Yale University. His experience in these renowned organizations has allowed him to collaborate with leading experts in the field of cancer research.

Collaborations

Some of Hal K Berman's notable coworkers include Thea D Tlsty and Mona L Gauthier. Their collaborative efforts have contributed to advancements in cancer detection and treatment methodologies.

Conclusion

Hal K Berman's innovative work in cancer biomarkers and detection methods highlights his commitment to improving healthcare outcomes. His contributions to the field are invaluable and continue to influence cancer research and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…